Word

ZEALAND PHARMA A/S

Status

Registered

Status Code

700

Status Date

Tuesday, October 30, 2018

Serial Number

86842067

Registration Number

5597662

Registration Date

Tuesday, October 30, 2018

Mark Type

4000

Filing Date

Tuesday, December 8, 2015

Trademark Owner History

Zealand Pharma A-S - Original Registrant

Classifications

5 (Based on Section 44(e)) Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders; first aid kits; diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders

1 (Based on Section 44(e)) Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; peptide substrates used in analyzing and detecting certain toxins for laboratory or research use

44 (Based on Section 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dentistry services; medical analysis of peptide based medicines for the diagnosis and treatment of persons; pharmaceutical advice; medical consulting services in the field of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders

42 (Based on Section 44(e)) Scientific and technological services and research and design relating thereto in the field of medicine, pharmaceuticals, genetics, biology and biotechnology, namely, research, design of peptides and pharmaceutical drugs, medical and scientific laboratory services, scientific and medical research consulting services, and medical research, analysis and testing in the field of diseases, illnesses and ailments in humans and animals for scientific and research purposes, namely, in the fields of endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, and skin disorders; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; design and development of computer hardware and software; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services, namely, the development of medicines for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid, namely, information and consultancy services relating to the development of medicines for the treatment of diseases, illnesses and ailments in humans and animals, namely, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders

"PHARMA A/S"

Trademark Events

Oct 30, 2023

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Jun 23, 2022

Assignment Of Ownership Not Updated Automatically

Feb 4, 2022

Assignment Of Ownership Not Updated Automatically

Nov 23, 2021

Applicant/Correspondence Changes (Non-Responsive) Entered

Nov 23, 2021

Teas Change Of Correspondence Received

Nov 23, 2021

Teas Change Of Domestic Representatives Address

Nov 23, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 23, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 23, 2021

Teas Change Of Owner Address Received

Oct 30, 2018

Registered-Supplemental Register

Sep 25, 2018

Law Office Publication Review Completed

Sep 25, 2018

Approved For Registration Supplemental Register

Sep 24, 2018

Teas/Email Correspondence Entered

Sep 24, 2018

Correspondence Received In Law Office

Sep 24, 2018

Teas Request For Reconsideration Received

May 29, 2018

Notification Of Subsequent Final Emailed

May 29, 2018

Subsequent Final Emailed

May 29, 2018

Subsequent Final Refusal Written

May 8, 2018

Assigned To Examiner

Apr 6, 2018

Teas/Email Correspondence Entered

Apr 5, 2018

Correspondence Received In Law Office

Apr 5, 2018

Teas Response To Office Action Received

Nov 21, 2017

Notification Of Priority Action E-Mailed

Nov 21, 2017

Priority Action E-Mailed

Nov 21, 2017

Priority Action Written

Oct 27, 2017

Teas/Email Correspondence Entered

Oct 27, 2017

Correspondence Received In Law Office

Oct 23, 2017

Teas Request For Reconsideration Received

Apr 28, 2017

Notification Of Final Refusal Emailed

Apr 28, 2017

Final Refusal E-Mailed

Apr 28, 2017

Final Refusal Written

Apr 6, 2017

Teas/Email Correspondence Entered

Apr 6, 2017

Correspondence Received In Law Office

Apr 6, 2017

Teas Response To Office Action Received

Jan 25, 2017

Applicant/Correspondence Changes (Non-Responsive) Entered

Jan 23, 2017

Assigned To Lie

Dec 29, 2016

Teas Withdrawal Of Attorney Received-Firm Retains

Oct 7, 2016

Notification Of Non-Final Action E-Mailed

Oct 7, 2016

Non-Final Action E-Mailed

Oct 7, 2016

Non-Final Action Written

Sep 16, 2016

Teas Change Of Correspondence Received

Sep 16, 2016

Teas/Email Correspondence Entered

Sep 16, 2016

Correspondence Received In Law Office

Sep 16, 2016

Teas Response To Office Action Received

Sep 16, 2016

Teas Withdrawal Of Attorney Received-Firm Retains

Mar 30, 2016

Notification Of Non-Final Action E-Mailed

Mar 30, 2016

Non-Final Action E-Mailed

Mar 30, 2016

Non-Final Action Written

Mar 25, 2016

Assigned To Examiner

Dec 11, 2015

New Application Office Supplied Data Entered

Dec 11, 2015

New Application Entered